Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction

Citation
R. Senior et al., Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction, AM HEART J, 137(4), 1999, pp. 646-652
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN HEART JOURNAL
ISSN journal
00028703 → ACNP
Volume
137
Issue
4
Year of publication
1999
Part
1
Pages
646 - 652
Database
ISI
SICI code
0002-8703(199904)137:4<646:CPRIPW>2.0.ZU;2-B
Abstract
Objective The aim of the study was to assess the effects of carvedilol, a v asodilating nonselective P-blocker, on the indexes of left ventricular remo deling after acute myocardial infarction in those with left ventricular dys function. Methods and Results Forty-nine patients with predischarge left ventricular election fraction <45% after acute myocardial infarction were evaluated in a double-blind, randomized, placebo-controlled, parallel group study (selec ted from the database of the Carvedilol Heart Attack Pilot Study: CHAPS). P atients received medication after thrombolysis and continued to do so for 6 months. Two-dimensional echocardiography was performed before discharge (7 to 10 days after admission) and at 3 months after acute myocardial infarct ion. Analysis of variance showed that wall thickness opposite the site of i nfarction decreased from (mean +/- SD) 12.3 +/- 2.1 mm to 11.0 +/- 2.4 mm w ith carvedilol compared with 11.6 +/- 1.9 mm to 12.2 +/- 1.9 mm with placeb o (P = .01). left ventricular mass changed from 235 +/- 74 g to 217 +/- 64 g with carvedilol compared with 227 +/- 80 g to 252 +/- 85 g with placebo ( P = .02). Carvedilol prevented alteration of sphericity index (ratio of lon g and short axis of left ventricle) that changed from 1.65 +/- 0.29 to 1.66 +/- 20 with carvedilol compared with 1.58 +/- 0.33 to 1.39 +/- 0.19 with p lacebo (P = .02); alteration was also prevented of wail thickening abnormal ity at infarct site, which changed from 9.2 +/- 3.1 cm(2) to 9.1 +/- 3.5 cm (2) with carvedilol compared with 10.3 +/- 3.3 cm(2) to 13.5 +/- 4.6 cm(2) with placebo (P = .002). Conclusion Carvedilol administered early after acute myocardial infarction results in attenuation of left ventricular remodeling in patients with pers istent left ventricular dysfunction before discharge.